Age (avg, years) |
60.2 ± 11.9 |
64.7 ± 11.0 |
0.30 |
Gender (male sex) (%) |
40 |
80 |
0.025 |
BMI (avg) |
35.9 ± 8.8 |
28.8 ± 3.6 |
0.01 |
Hypertension (%) |
80 |
67 |
0.43 |
Diabetes (%) |
0 |
13 |
0.16 |
ASCVD (%) |
40 |
67 |
0.15 |
Heart failure (%) |
20 |
40 |
0.25 |
Pacemaker (%) |
13 |
0 |
0.16 |
Paroxysmal/Persistent AF (%) |
60/27 |
53/47 |
0.72/0.27 |
Ejection fraction ≤50% (%) |
21 |
25 |
0.84 |
LVH (%) |
33 |
47 |
0.47 |
LA size - Volume/BSA (avg, cm2) |
38.7 ± 18.7 |
39.8 ±
17.9 |
0.89 |
LA dilation (%) |
53 |
60 |
0.72 |
Mitral Regurgitation (%) |
73 |
67 |
0.70 |
Oral anti-coagulant use (%) |
100 |
100 |
- |
Anti-arrhythmic drug use (%) |
53 |
60 |
0.72 |